Clinical Trial Detail

NCT ID NCT02546986
Title Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Celgene Corporation
Indications

lung non-small cell carcinoma

Therapies

Azacitidine

Pembrolizumab

Age Groups: adult

Additional content available in CKB BOOST